Review
Copyright ©The Author(s) 2021.
World J Gastroenterol. Oct 7, 2021; 27(37): 6191-6223
Published online Oct 7, 2021. doi: 10.3748/wjg.v27.i37.6191
Table 4 Artificial intelligence applications in gastroenterology: Prognosis
Ref.
Parameters employed
AI classifier
Sizes of the training/validation sets
Outcomes
Performance        
Yang et al[97]Laboratory results, immunomarkers, clinicopathological parametersSVM319/164 patientsDistant metastasis of oesophageal squamous cell carcinoma following surgery69.5-80.11,6, 44.7-67.23,6, 81.6-97.74,6
Sato et al[98]Laboratory results, clinicopathological parameters, tumor characteristicsANN395 patients (training:validation:test = 53:27:20)1-year and 5-year survival of patients with esophageal cancer following surgery0.883-0.8842,7, 78.1-80.73,7, 84.7-86.54,7
Zhou et al[99]Laboratory results, clinicopathological parameters, tumor characteristicsSeveral2012 patients (training:validation = 8:2)Recurrence of gastric cancer following surgery0.790-0.9622,5, 0.771-0.7952,6
Peng et al[100]Meteorological dataANN901 patientsVariations of onset and relapse of IBDs----
Hardalaç et al[101]Clinicopathological parameters, treatment dataANN129 patients (training:validation:test = 80:10:10)Prediction of mucosal remission for CD patients treated with azathioprine58.1-79.11,6, 0.527-0.8832,6
Takayama et al[102]Clinicopathological parameters, treatment dataANN54/36 patientsPrediction of the need for operation for UC patients treated with cytoapheresis963,6, 974,6
Lyles et al[103]Laboratory results, clinicopathological parametersCART884 patientsPrediction of in-hospital mortality of upper GIB in cirrhotic patients----
Grossi et al[104]Laboratory results, clinicopathological parametersANN807 patients30-d mortality of patients with non-variceal upper GIB81.2-89.01,6, 0.872,6, 81.5-93.33,6, 80.9-84.74,6
Rotondano et al[105]Laboratory results, clinicopathological parametersANN2380 patients30-d mortality of patients with non-variceal upper GIB96.81,6, 0.952,6, 83.83,6, 97.54,6
Shi et al[106]CT radiomicsSeveral124/35 patientsPrediction of the presence of RAS and BRAF mutations in CRCANN: 871,5, 711,6, 0.90-0.952,5, 0.792,6
Kang et al[107]Laboratory results, immunomarkers, clinicopathological parameters, tumor characteristicsLASSO221/95 patientsPrediction of lymph node metastasis status in operated patients for T1 CRC 0.7952,5, 0.7652,6